Study of diffusion weighted MRI as a predictive biomarker of response during radiotherapy for high and intermediate risk squamous cell cancer of the oropharynx:

Slides:

Advertisements

Similar presentations

Cancer Metabolism Cell Volume 148, Issue 3, (February 2012) DOI: /j.cell Copyright © 2012 Terms and Conditions Terms and Conditions.

Advertisements

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Non-randomized comparison between definitive concurrent chemoradiotherapy and pre- operative radiotherapy followed by surgery in patients with hypopharyngeal.

Lactate-Base 1H Magnetic Spectroscopy Does Not Predict Response and Outcomes in Patients With Stage IV Head and Neck Squamous Cell Carcinoma Q. Le, A.

A New Model for Imaging and Radiation Therapy Quality Assurance in the National Clinical Trials Network of the National Cancer Institute Thomas J. FitzGerald,

Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial Susanne M.

Higher-Than-Conventional Radiation Doses in Localized Prostate Cancer Treatment: A Meta-analysis of Randomized, Controlled Trials Gustavo Arruda Viani,

P. Therasse, S. Carbonnelle, J. Bogaerts

Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced.

Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO)

SYSTEMS-2: A randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma M. Ashton, N. O'Rourke, N.

Single nucleotide polymorphisms might influence chemotherapy induced nausea in women with breast cancer Delmy Oliva, Mats Nilsson, Bengt-Åke Andersson,

The Path(way) Less Traveled: A Pathway-Oriented Approach to Providing Information about Precision Cancer Medicine on My Cancer Genome Alexandria D. Taylor,

Improved outcome of treating locally advanced lung cancer with the use of Lattice Radiotherapy (LRT): A case report Beatriz E. Amendola, Naipy C. Perez,

Profiling of a panel of radioresistant prostate cancer cells identifies deregulation of key miRNAs McDermott Niamh , Meunier Armelle , Wong Simon , Buchete.

In This Issue Cell Volume 158, Issue 5, (August 2014)

Patient-reported symptoms and performance status before palliative radiotherapy in geriatric cancer patients (octogenarians) Carsten Nieder, Thomas A.

Surgery vs. primary radiotherapy in early-stage oropharyngeal cancer

Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era Ryan S. Youland, Miran L. Blanchard, Roxanna Dronca, Lisa Kottschade,

Electronic Updates for JTO Readers

VMAT radiation-induced nausea and vomiting in adjuvant breast cancer radiotherapy: The incidental effect of low-dose bath exposure G. Lazzari, A. Terlizzi,

Volume 26, Issue 2, Pages (February 2018)

PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed.

Harald P. Hoensch, Reinhard Oertel Clinical Nutrition Experimental

When Should Screening Stop for Elderly Individuals at Average and Increased Risk for Colorectal Cancer? Folasade P. May, Samir Gupta Clinical Gastroenterology.

Jojanneke M. Seinen, Maarten G

Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer Amar U. Kishan, Rahul.

Axillary radiotherapy for nodal lymphoma: What CTV expansion is required to account for absence of pre-chemotherapy treatment position FDG PET-CT? Robin.

Changes in apparent diffusion coefficient radiomics features during dose-painted radiotherapy and high dose rate brachytherapy for prostate cancer Sangjune.

Volume 152, Issue 1, (January 2013)

Potentials and challenges of diffusion-weighted magnetic resonance imaging in radiotherapy Sara Leibfarth, René M. Winter, Heidi Lyng, Daniel Zips, Daniela.

Clinical and Translational Radiation Oncology

Simultaneous integrated prophylactic cranial irradiation in sino-nasal cancer Kenneth Jensen, Maja Bendtsen Sharma, Simon Lenler-Eriksen, Per Friis, Anne.

Follow up results of a prospective study to evaluate the impact of FDG-PET on CT- based radiotherapy treatment planning for oesophageal cancer Sweet Ping.

Evaluating the prevalence and predictive factors of vasomotor and psychological symptoms in prostate cancer patients receiving hormonal therapy: Results.

Age-not Charlson Co-morbidity Index-predicts for mortality after stereotactic ablative radiotherapy for medically inoperable stage I non-small cell lung.

Volume 130, Issue 6, (September 2007)

Impact of waiting time on nodal staging in head and neck squamous-cell carcinoma treated with radical intensity modulated radiotherapy Cédric Chevalier,

Feasibility of stereotactic body radiotherapy for locally-advanced non-small cell lung cancer Katrina Woodford, Vanessa Panettieri, Trieumy Tran Le,

Jean-Emmanuel Bibault, Ingeborg Tinhofer

What is the impact of diabetes mellitus on radiation induced acute proctitis after radical radiotherapy for adenocarcinoma prostate? A prospective longitudinal.

Support Your Specialty

A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the.

Volume 143, Issue 6, (December 2010)

Clinical and radiobiological evaluation of a method for planning target volume generation dependent on organ-at-risk exclusions in magnetic resonance.

Volume 17, Issue 2, Pages (February 1950)

Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancer Garrett L. Jensen, Pierre Blanchard, G. Brandon Gunn, Adam.

D.J. Hunter Osteoarthritis and Cartilage

The posterior cerebellum, a new organ at risk?

Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas Debra Nana Yeboa, James B. Yu,

Clinical application of Total Skin Electron Beam (TSEB) therapy for the management of T cell cutaneous lymphomas. The evolving role of low dose (12 Gy)

Telehealth in radiation oncology at the Townsville Cancer Centre: Service evaluation and patient satisfaction Elizabeth Hamilton, Ellie Van Veldhuizen,

Rectal volume variations and estimated rectal dose during 8 weeks of image-guided radical 3D conformal external beam radiotherapy for prostate cancer

Plasma proteins as prognostic biomarkers in radiotherapy treated head and neck cancer patients Line Brøndum, Jesper Grau Eriksen, Brita Singers Sørensen,

Genetic Changes in Squamous Cell Lung Cancer: A Review

Squamous Cell Carcinoma of the Tongue

Beware the malignant jellyfish

Patterns of practice in palliative radiotherapy for bleeding tumours in the Netherlands; a survey study among radiation oncologists Jennifer Strijbos,

Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma Julianna K. Bronk, Nandita Guha-Thakurta,

PS01.07 The Clinical Necessity of Extended Thymectomy for Thymic Squamous Cell Carcinomas Revealed by Exome Sequencing J. Jiang, Y. Zhang, C. Jin, J.

Jan Roigas European Urology Supplements

Volume 163, Issue 4, (November 2015)

Volume 4, Issue 1, Pages 2-3 (February 2006)

Volume 163, Issue 2, (October 2015)

Clinical and Translational Radiation Oncology

Volume 134, Issue 6, (September 2008)

Clinical and Translational Radiation Oncology

In This Issue Cell Volume 145, Issue 3, (April 2011)

A Review of First-Line Treatment for Small-cell Lung Cancer

Volume 148, Issue 1, (January 2012)

Presentation transcript:

Study of diffusion weighted MRI as a predictive biomarker of response during radiotherapy for high and intermediate risk squamous cell cancer of the oropharynx: The MeRInO study C Paterson, S Allwood-Spiers, I McCrea, J Foster, M McJury, M Thomson, M Sankaralingam, D Grose, A James, M Rizwanullah, P McLoone, A Chalmers, A Duffton Clinical and Translational Radiation Oncology Volume 2, Pages 13-18 (February 2017) DOI: 10.1016/j.ctro.2016.12.003 Copyright © 2017 The Authors Terms and Conditions

Fig. 1 Trial pathway. Clinical and Translational Radiation Oncology 2017 2, 13-18DOI: (10.1016/j.ctro.2016.12.003) Copyright © 2017 The Authors Terms and Conditions